98%
921
2 minutes
20
Objective: The success of engineered tissues continues to be limited by time to vascularization and perfusion. Recently, we described a simple microsurgical approach, termed micropuncture (MP), which could be used to rapidly vascularize an adjacently placed scaffold from the recipient macrovasculature. Here we studied the long-term persistence of the MP-induced microvasculature.
Methods: Segmental 60 μm diameter MPs were created in the recipient rat femoral artery and vein followed by coverage with a simple Type 1 collagen scaffold. The recipient vasculature and scaffold were then wrapped en bloc with a silicone sheet to isolate intrinsic vascularization. Scaffolds were harvested at 28 days post-implantation for detailed analysis, including using a novel artificial intelligence (AI) approach.
Results: MP scaffolds demonstrated a sustained increase of vascular density compared to internal non-MP control scaffolds (p < 0.05) secondary to increases in both vessel diameters (p < 0.05) and branch counts (p < 0.05). MP scaffolds also demonstrated statistically significant increases in red blood cell (RBC) perfused lumens.
Conclusions: This study further highlights that the intrinsic MP-induced vasculature continues to persist long-term. Its combination of rapid and stable angiogenesis represents a novel surgical platform for engineered scaffold and graft perfusion.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10842157 | PMC |
http://dx.doi.org/10.1111/micc.12835 | DOI Listing |
Cureus
August 2025
Cellular Biology and Anatomy, Louisiana State University Health Sciences Center, Shreveport, USA.
Background and aims The alpha-galactosidase (αGal) epitope and the associated anti-Gal antibodies, along with the non-human sialic acid N-glycolylneuraminic acid (Neu5Gc) and its corresponding anti-Neu5Gc antibodies, represent critical obstacles in the field of xenotransplantation. We present an evaluation of serological and histopathological data from patients who experienced immunological rejection after receiving decellularized xenografts. This study aims to analyze the long-term immune responses that occur following the implantation of these grafts, providing insights into the mechanisms driving rejection and their potential impact on transplant outcomes.
View Article and Find Full Text PDFChem Eng J
September 2025
Wallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine and Georgia Institute of Technology, Atlanta, GA, United States.
Cardiac patch-based regenerative therapies have shown great promise in the treatment of myocardial infarction (MI). The clinical applications of patch devices, however, face major limitations mainly due to the inadequate integration of typically nonvascular implanted grafts with the recipient heart muscle tissue, the lack of patient and damage specificity, and insufficient perfusion. Here we present a new generation of cardiac patch devices with customized geometry and vasculature to closely correspond to those of the recipient heart tissue, while providing imaging properties.
View Article and Find Full Text PDFCurr Issues Mol Biol
April 2025
Shriners Children's Boston, Boston, MA 02114, USA.
Vascularized composite allotransplantation (VCA) has emerged as a robust alternative for addressing anatomically complex defects but requires a toxic lifelong immunosuppressive regimen. Tissue engineering offers the promise of creating recipient-specific alternative grafts using a decellularization and recellularization approach. In this article, we establish a reliable protocol for human face decellularization by immersion as a new tool in the development of engineered graft alternatives for reconstructive surgery.
View Article and Find Full Text PDFSci Rep
July 2025
Department of Mechanical and Industrial Engineering, Faculty of Applied Science and Engineering, University of Toronto, 5 King's College Road, Toronto, ON, M5S 3G8, Canada.
Transplantation of donor grafts recellularized with recipient-derived or non-immunogenic universal cells is a potential means of reducing the graft rejection and post-transplant complications in lung transplantation. Achieving a fully recellularized lung, however, remains a far-off goal and has several limitations, including inadequate cell coverage of the acellular scaffold. A key parameter for evaluating recellularization efficacy is the cell seeding coverage (CSC); the ratio of seeded cell area to the total area of the lung scaffold.
View Article and Find Full Text PDFInt J Surg
July 2025
Department of Burn and Plastic Surgery, Guangzhou First People's Hospital, Guangzhou, Guangdong, China.
Background: Materials for small-caliber vascular stents are deficient, with acellular vascular scaffold (AVS) being a promising solution. Platelet-rich plasma (PRP) sourced from the recipient augments the biocompatibility of vascular graft materials. Through integration of PRP onto AVS materials, our goal is to bolster AVS biocompatibility within the body, elevate the M2/M1 macrophage ratio toward graft materials for low degradation rate, and foster robust heparin attachment onto the surface of AVS materials.
View Article and Find Full Text PDF